A citation-based method for searching scientific literature

Daniel Almquist, Vinicius Ernani. JCO Oncol Pract 2021
Times Cited: 2







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases.
Richard S P Huang, James Haberberger, Ethan Sokol, Alexa B Schrock, Natalie Danziger, Russell Madison, Sally Trabucco, Dexter Jin, Dean Pavlick, Vivek Ramanan,[...]. Int J Cancer 2021
5
100

Efficacy of Crizotinib among Different Types of ROS1 Fusion Partners in Patients with ROS1-Rearranged Non-Small Cell Lung Cancer.
Ziming Li, Lan Shen, Ding Ding, Jia Huang, Jie Zhang, Zhiwei Chen, Shun Lu. J Thorac Oncol 2018
44
100

High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden.
Ryma Benayed, Michael Offin, Kerry Mullaney, Purvil Sukhadia, Kelly Rios, Patrice Desmeules, Ryan Ptashkin, Helen Won, Jason Chang, Darragh Halpenny,[...]. Clin Cancer Res 2019
163
100

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
F Mosele, J Remon, J Mateo, C B Westphalen, F Barlesi, M P Lolkema, N Normanno, A Scarpa, M Robson, F Meric-Bernstam,[...]. Ann Oncol 2020
180
100

Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples.
Kurtis D Davies, Anh T Le, Jamie Sheren, Hala Nijmeh, Katherine Gowan, Kenneth L Jones, Marileila Varella-Garcia, Dara L Aisner, Robert C Doebele. J Thorac Oncol 2018
86
100

ROS1-dependent cancers - biology, diagnostics and therapeutics.
Alexander Drilon, Chelsea Jenkins, Sudarshan Iyer, Adam Schoenfeld, Clare Keddy, Monika A Davare. Nat Rev Clin Oncol 2021
31
100

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.
Véronique Hofman, Isabelle Rouquette, Elodie Long-Mira, Nicolas Piton, Emmanuel Chamorey, Simon Heeke, Jean Michel Vignaud, Clémence Yguel, Julien Mazières, Anne-Laure Lepage,[...]. J Thorac Oncol 2019
23
100

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.
Rafal Dziadziuszko, Matthew G Krebs, Filippo De Braud, Salvatore Siena, Alexander Drilon, Robert C Doebele, Manish R Patel, Byoung Chul Cho, Stephen V Liu, Myung-Ju Ahn,[...]. J Clin Oncol 2021
12
100

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
J Mazieres, A Drilon, A Lusque, L Mhanna, A B Cortot, L Mezquita, A A Thai, C Mascaux, S Couraud, R Veillon,[...]. Ann Oncol 2019
345
100

Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization.
Richard S P Huang, Derek Smith, Catherine H Le, Wen-Wei Liu, Ellen Ordinario, Chitra Manohar, Michael Lee, Jaya Rajamani, Huan Truong, Jing Li,[...]. Arch Pathol Lab Med 2020
13
100

BRAF in Lung Cancers: Analysis of Patient Cases Reveals Recurrent BRAF Mutations, Fusions, Kinase Duplications, and Concurrent Alterations.
Yuri Sheikine, Dean Pavlick, Samuel J Klempner, Sally E Trabucco, Jon H Chung, Mark Rosenzweig, Kai Wang, Vamsidhar Velcheti, Garrett M Frampton, Nir Peled,[...]. JCO Precis Oncol 2018
15
50

EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.
Kartik Konduri, Jean-Nicolas Gallant, Young Kwang Chae, Francis J Giles, Barbara J Gitlitz, Kyle Gowen, Eiki Ichihara, Taofeek K Owonikoko, Vijay Peddareddigari, Suresh S Ramalingam,[...]. Cancer Discov 2016
63
50

Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue.
Shinkichi Takamori, Taichi Matsubara, Naoki Haratake, Gouji Toyokawa, Takatoshi Fujishita, Ryo Toyozawa, Kensaku Ito, Masafumi Yamaguchi, Kenichi Taguchi, Tatsuro Okamoto,[...]. Front Oncol 2021
1
100

A Performance Comparison of Commonly Used Assays to Detect RET Fusions.
Soo-Ryum Yang, Umut Aypar, Ezra Y Rosen, Douglas A Mata, Ryma Benayed, Kerry Mullaney, Gowtham Jayakumaran, Yanming Zhang, Denise Frosina, Alexander Drilon,[...]. Clin Cancer Res 2021
9
50

The Promising Evolution of Targeted Therapeutic Strategies in Cancer.
Solange Peters, Tony Mok, Antonio Passaro, Pasi Antero Jänne. Cancer Discov 2021
5
50

Lung Adenocarcinoma With Primary LIMD1-BRAF Fusion Treated With MEK Inhibitor: A Case Report.
Cheng-You Wang, Jiun-Yi Hsia, Che-Hsing Li, Chao-Chi Ho, Wan-Ru Chao, Ming-Fang Wu. Clin Lung Cancer 2021
2
50

The transcriptional landscape and mutational profile of lung adenocarcinoma.
Jeong-Sun Seo, Young Seok Ju, Won-Chul Lee, Jong-Yeon Shin, June Koo Lee, Thomas Bleazard, Junho Lee, Yoo Jin Jung, Jung-Oh Kim, Jung-Young Shin,[...]. Genome Res 2012
396
50

A Patient With Lung Adenocarcinoma With BRAF Gene Fusion and Response to Vemurafenib.
You-Cai Zhu, Wen-Xian Wang, Chun-Wei Xu, Wu Zhuang, Kai-Qi Du, Gang Chen, Tang-Feng Lv, Yong Song. Clin Lung Cancer 2019
7
50

Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement.
Jan Budczies, Daniel Kazdal, Michael Allgäuer, Petros Christopoulos, Eugen Rempel, Nicole Pfarr, Wilko Weichert, Stefan Fröhling, Michael Thomas, Solange Peters,[...]. Lung Cancer 2020
14
50

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J Piper-Vallillo, Hollis Viray, Adeel M Khan, Deepa Rangachari, Daniel B Costa. Precis Cancer Med 2020
11
50

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
James P Solomon, Irina Linkov, Andrea Rosado, Kerry Mullaney, Ezra Y Rosen, Denise Frosina, Achim A Jungbluth, Ahmet Zehir, Ryma Benayed, Alexander Drilon,[...]. Mod Pathol 2020
173
50


NUT carcinoma of the lung.
Sylvie Lantuejoul, Daniel Pissaloux, Gilbert R Ferretti, Anne McLeer. Semin Diagn Pathol 2021
2
50

Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing.
Esther Conde, Federico Rojo, Javier Gómez, Ana Belén Enguita, Ihab Abdulkader, Ana González, Dolores Lozano, Nuria Mancheño, Clara Salas, Marta Salido,[...]. J Clin Pathol 2022
4
50

How selecting best upfront therapy for metastatic disease?-Focus on ROS1-rearranged disease.
Lorenza Landi, Federico Cappuzzo. Transl Lung Cancer Res 2020
2
50

Supercharging BRD4 with NUT in carcinoma.
Kyle P Eagen, Christopher A French. Oncogene 2021
10
50

Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas.
Matthias S Matter, Obinna Chijioke, Spasenija Savic, Lukas Bubendorf. Transl Lung Cancer Res 2020
7
50

ALK Rearrangement in Lung Neuroendocrine Neoplasms: Case Series of Non-Asian Patients With Response to ALK Inhibitors.
Helene Doubre, Severine Fraboulet, Elisabeth Longchampt, Diane Damotte, Audrey Lupo, Louis-Jean Couderc, Matthieu Glorion, Segolene Hescot. Clin Lung Cancer 2021
1
100

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay.
Simon Heeke, Jonathan Benzaquen, Audrey Vallee, Maryline Allegra, Julien Mazieres, Julien Fayada, Jaya Rajamani, Michael Lee, Ellen Ordinario, Angelica Tiotiu,[...]. Ann Transl Med 2021
2
50

DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks.
Alice Guyard, Alice Boyez, Anaïs Pujals, Cyrielle Robe, Jeanne Tran Van Nhieu, Yves Allory, Julien Moroch, Odette Georges, Jean-Christophe Fournet, Elie-Serge Zafrani,[...]. Virchows Arch 2017
43
50

RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer.
Caterina De Luca, Francesco Pepe, Antonino Iaccarino, Pasquale Pisapia, Luisella Righi, Angela Listì, Lorenza Greco, Gianluca Gragnano, Severo Campione, Gianfranco De Dominicis,[...]. Cancers (Basel) 2021
7
50

Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
Nicole Pfarr, Martina Kirchner, Ulrich Lehmann, Jonas Leichsenring, Sabine Merkelbach-Bruse, Julia Glade, Michael Hummel, Fabian Stögbauer, Annika Lehmann, Marcel Trautmann,[...]. Genes Chromosomes Cancer 2020
31
50

Detection of Known and Novel FGFR Fusions in Non-Small Cell Lung Cancer by Comprehensive Genomic Profiling.
Angel Qin, Adrienne Johnson, Jeffrey S Ross, Vincent A Miller, Siraj M Ali, Alexa B Schrock, Shirish M Gadgeel. J Thorac Oncol 2019
32
50

Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis.
Arlou Kristina Angeles, Petros Christopoulos, Zhao Yuan, Simone Bauer, Florian Janke, Simon John Ogrodnik, Martin Reck, Matthias Schlesner, Michael Meister, Marc A Schneider,[...]. NPJ Precis Oncol 2021
1
100

Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer.
Mark Kriegsmann, Christian Haag, Cleo-Aron Weis, Georg Steinbuss, Arne Warth, Christiane Zgorzelski, Thomas Muley, Hauke Winter, Martin E Eichhorn, Florian Eichhorn,[...]. Cancers (Basel) 2020
14
50

Artificial intelligence as the next step towards precision pathology.
B Acs, M Rantalainen, J Hartman. J Intern Med 2020
64
50

Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies.
Petros Christopoulos, Steffen Dietz, Arlou K Angeles, Stephan Rheinheimer, Daniel Kazdal, Anna-Lena Volckmar, Florian Janke, Volker Endris, Michael Meister, Mark Kriegsmann,[...]. Transl Lung Cancer Res 2021
6
50

A Catalog of 5' Fusion Partners in ROS1-Positive NSCLC Circa 2020.
Sai-Hong Ignatius Ou, Misako Nagasaka. JTO Clin Res Rep 2020
3
50

Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA.
Julianna G Supplee, Marina S D Milan, Lee P Lim, Kristy T Potts, Lynette M Sholl, Geoffrey R Oxnard, Cloud P Paweletz. Lung Cancer 2019
45
50

Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel Kazdal, Julia Glade, Michael Allgäuer, Mark Kriegsmann, Claus-Peter Heußel, Felix J Herth, Hauke Winter,[...]. Cancer Immunol Immunother 2022
1
100


Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene?
Nobuaki Ochi, Hiromichi Yamane, Tomoko Yamagishi, Nagio Takigawa, Yasumasa Monobe. Lung Cancer 2013
10
50

Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake.
Alessandro De Toma, Giuseppe Lo Russo, Diego Signorelli, Filippo Pagani, Giovanni Randon, Giulia Galli, Arsela Prelaj, Roberto Ferrara, Claudia Proto, Monica Ganzinelli,[...]. Crit Rev Oncol Hematol 2021
3
50

Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry.
Alexander Drilon, Michael Duruisseaux, Ji-Youn Han, Masaoki Ito, Christina Falcon, Soo-Ryum Yang, Yonina R Murciano-Goroff, Haiquan Chen, Morihito Okada, Miguel Angel Molina,[...]. J Clin Oncol 2021
9
50

KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma.
Hui Xu, Chuan Shao. Onco Targets Ther 2020
7
50

Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population.
Yunjian Pan, Yang Zhang, Ting Ye, Yue Zhao, Zhendong Gao, Hui Yuan, Difan Zheng, Shanbo Zheng, Hang Li, Yuan Li,[...]. J Thorac Oncol 2019
31
50

Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1-ALK-rearranged lung cancer.
Steffen Dietz, Petros Christopoulos, Lisa Gu, Anna-Lena Volckmar, Volker Endris, Zhao Yuan, Simon J Ogrodnik, Tomasz Zemojtel, Claus-Peter Heussel, Marc A Schneider,[...]. Cold Spring Harb Mol Case Stud 2019
8
50

Efficacy and Safety of Neoadjuvant Targeted Therapy vs. Neoadjuvant Chemotherapy for Stage IIIA EGFR-Mutant Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Dong Chen, Zixian Jin, Jian Zhang, Congcong Xu, Kanghao Zhu, Yuhang Ruan, Bo Zhang, Baofu Chen, Jianfei Shen. Front Surg 2021
1
100

FGFR3-TACC3 fusion in solid tumors: mini review.
Ricardo Costa, Benedito A Carneiro, Timothy Taxter, Fabio A Tavora, Aparna Kalyan, Sachin A Pai, Young Kwang Chae, Francis J Giles. Oncotarget 2016
68
50

Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase.
Patricia J T A Groenen, Willeke A M Blokx, Coos Diepenbroek, Lambert Burgers, Franco Visinoni, Pieter Wesseling, Johan H J M van Krieken. Histopathology 2011
34
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.